Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse
Bibliographic Data
| ID | 11680588 |
|---|---|
| Authors | Anca Cotet Grecu (0000-0003-3028-254X, corresponding author), Anca M Grecu, Dhaval M Dave, Dhaval Dave (0000-0003-4514-3761), Henry Saffer (0000-0001-8433-6924) |
| Year | 2018 |
| Volume | 38 |
| Issue | 1 |
| Pages | 181-209 |
| Publication date | 2018-10-15 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Policy Analysis and Management (JOURNAL) |
| Journal identifiers | ISSN: 0276-8739 • E-ISSN: 1520-6688 |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1002/pam.22098 |
| PMID | 30572414 |
| OpenAlex | W2635328096 |
| Language | EN |
| Citations received | 16 |
| References cited | 42 |
Despite the significant cost of prescription (Rx) drug abuse and calls from policymakers for effective interventions, there is limited research on the effects of policies intended to limit such abuse. This study estimates the effects of prescription drug monitoring (PDMP) programs, which constitute a key policy targeting access to non-medical use of Rx drugs. Based on objective indicators of abuse as measured by substance abuse treatment admissions and mortality related to Rx drugs, estimates do not suggest any substantial effects of instituting an operational PDMP. We find, however, that mandatory-access provisions, which raised PDMP utilization rates by actually requiring providers to query the PDMP prior to prescribing a controlled drug, are significantly associated with a reduction in Rx drug abuse. The effects are driven primarily by a reduction in opioid abuse, generally strongest among young adults (ages 18 to 24), and underscore important dynamics in the policy response. Robustness checks are consistent with a causal interpretation of these effects. We also assess potential spillovers of mandatory PDMPs on the use of other illicit drugs and find a complementary reduction in admissions related to cocaine and marijuana abuse
Controlled substance · Drug · Medical prescription · Opioid · Prescription drug · Prescription Drug Misuse · Psychiatry · Psychological intervention · Substance abuse · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes · Pharmacology
Drivers of the fatal drug epidemic
Prescription drug monitoring programs and neonatal outcomes
Association between prescription drug monitoring programs use mandates and prescription stimulants received by Medicaid enrollees
Mapping the research addressing prescription drug monitoring programs
City Nuisance Ordinances and Overdose Mortality
The effect of opioids on crime
Prescription Drug Monitoring Program Reminder Emails, Program Use, and Prescribing
Effect of Integrating Access to a Prescription Drug Monitoring Program Within the Electronic Health Record on the Frequency of Queries by Primary Care Clinicians
The economic underpinnings of the drug epidemic
The impact of prescription drug monitoring programs on functional health
Factors Associated with the Writing of Opioid Prescriptions
Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities
Fighting abuse with prescription tracking
The Opioid Crisis, Health, Healthcare, and Crime
The Opioid Epidemic Was Not Caused by Economic Distress but by Factors That Could Be More Rapidly Addressed
The relationship of opioid prescriptions and the educational performance of children
Mostly Harmless Econometrics
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015
Macroeconomic conditions and opioid abuse
Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century
Assessing the Effects of Medical Marijuana Laws on Marijuana Use
Substance abuse treatment centers and local crime
Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioids
The Effect of State Policies on the Location of Manufacturing
The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013
| Unique citing works | 16 |
|---|---|
| Citations per year | 2,29 |
| Citation span | 2019 - 2026 (8) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 16 |